课题基金 / 基金详情

MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES

MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES
心肌再灌注损伤的机制--糖尿病
批准号:
6184820
负责人:
DAVID JOSEPH LEFER
金额:
$17.7万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2003-04-30

项目摘要

项目成果

DAVID JOSEPH LEFER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the applicant's description): This study is focused on the neutrophil mediated tissue injury during inflammation of the reperfused myocardium. The application is revised according to previous review as a R29. The general premise is that the severity of reperfusion injury appears to be a greater risk factor in hearts of diabetics than in non-diabetics. Thus, the central hypothesis is that enhanced neutrophil recruitment and activation is responsible for greater vulnerability of diabetic myocardium to ischemic/ reperfusion induced tissue necrosis. The applicant proposes to investigate the molecular mechanisms involved in the inflammatory response that is associated with reperfusion injury in a db/db strain of diabetic mice and in streptozotocin treated mice. The experimental plan will utilize an in vivo model of coronary artery ligation and reperfusion. Monoclonal antibodies will be used for in vivo quantification of endothelial cell adhesion molecules (ECAM). The extent of neutrophil accumulation, contractile function, and cell necrosis will also be examined to assess the vulnerability of the diabetic heart to ischemia/reperfusion damage. The applicant also intends to evaluate anti-inflammatory therapies on ECAM expression, leukocyte recruitment, and cell damage. Several strains of transgenic mice, as knockout models of cytokine or cell adhesion molecule deficiencies, are also to be tested for the extent of reperfusion injury following streptozotocin treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hydrogen Sulfide Regulation in Cardioprotection
  • 批准号:
    10391506
  • 项目类别:
  • 资助金额:
    $56.2万
  • 财政年份:
    2020
  • 负责人:
    DAVID JOSEPH LEFER
  • 依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
  • 批准号:
    10162413
  • 项目类别:
  • 资助金额:
    $57.6万
  • 财政年份:
    2020
  • 负责人:
    DAVID JOSEPH LEFER
  • 依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
  • 批准号:
    10610727
  • 项目类别:
  • 资助金额:
    $54.7万
  • 财政年份:
    2020
  • 负责人:
    DAVID JOSEPH LEFER
  • 依托单位:
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
  • 批准号:
    10077584
  • 项目类别:
  • 资助金额:
    $40.13万
  • 财政年份:
    2019
  • 负责人:
    DAVID JOSEPH LEFER
  • 依托单位:
海外基金